EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma
- 1 March 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (3), 713-723
- https://doi.org/10.1016/s0360-3016(02)04357-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- EGFR overexpression and radiation response in glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 2001
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001
- The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapyEuropean Journal Of Cancer, 2001
- Ionizing Radiation-Induced Mitogen-Activated Protein (MAP) Kinase Activation in DU145 Prostate Carcinoma Cells: MAP Kinase Inhibition Enhances Radiation-Induced Cell Killing and G2/M-Phase ArrestRadiation Research, 2000
- Radiation-induced Release of Transforming Growth Factor α Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell DeathMolecular Biology of the Cell, 1999
- The Epidermal Growth Factor Receptor and Its Inhibition in Cancer TherapyPharmacology & Therapeutics, 1999
- Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervixZeitschrift für Krebsforschung und Klinische Onkologie, 1998
- Correlation of Epidermal Growth Factor Receptor and Radiosensitivity in Human Maxillary Carcinoma Cell LinesActa Oto-Laryngologica, 1998
- Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neckRadiation Oncology Investigations, 1997
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995